Read More

Illinois governor touts his state’s cannabis social equity program: Poised to be ‘national standard’

Illinois Gov. J.B. Pritzker asserted Thursday that his state’s cannabis social equity program is thus far the most successful in the nation during a speech to a room full of marijuana industry attorneys. Pritzker, who gave the keynote address at the seventh annual Cannabis Law Institute held in Chicago this …

Read More

Michigan lawmakers propose merging medical, recreational cannabis licenses

This story was republished with permission from Crain’s Detroit and written by Dustin Walsh.  Michigan lawmakers are seeking to simplify Michigan’s marijuana regulations. State Reps. Graham Filler, a Republican from St. Johns, and Jimmie Wilson Jr., a Democrat from Ypsilanti, introduced legislation to merge the state’s existing medical marijuana and recreational marijuana frameworks …

Only One In Four Marijuana Businesses Are Profitable, Yet Optimism Prevails Amid Rescheduling Push, Industry Survey Finds

Just one in four marijuana businesses are profitable, according to a new survey. Yet optimism about the future of their enterprises has increased on the heels of the Biden administration’s push to reschedule marijuana. The new survey data from Whitney Economics, which was partly detailed in a public comment on the federal government’s pending marijuana

Read More

New Mexico Cookies retailer agrees to $350,000 settlement over opening-day violations

Blue Whale Enterprises Inc., which operates a dispensary under the Cookies brand name in New Mexico, agreed to pay $350,000 in fees to settle allegations of multiple violations during its grand opening event last year, according to a settlement agreement released by regulators. The New Mexico Cannabis Control Division alleged …

Read More

Johnson & Johnson requests FDA nod for Spravato as solo depression therapy

Johnson & Johnson (NYSE: JNJ) has asked U.S. regulators to approve its nasal spray Spravato as a standalone treatment for adults with treatment-resistant depression, the company announced Monday. The pharmaceutical giant is seeking to expand the use of Spravato, which is currently approved only in combination with oral antidepressants. Approval …